Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
Condition(s):Major Depressive DisorderLast Updated:June 9, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Major Depressive DisorderLast Updated:June 9, 2021Completed
Condition(s):Major Depressive DisorderLast Updated:June 9, 2021Completed
Condition(s):Bipolar DisorderLast Updated:March 12, 2024Terminated
Condition(s):Depressive Disorder, Treatment-ResistantLast Updated:June 2, 2020Completed
Condition(s):Lactating Women on Select DOI; Breastfed Infants of Mothers on Select DOILast Updated:January 25, 2024Recruiting
Condition(s):Major DepressionLast Updated:November 16, 2022Completed
Condition(s):PTSDLast Updated:November 9, 2023Active, not recruiting
Condition(s):Major Depressive DisorderLast Updated:October 17, 2016Unknown status
Condition(s):Schizophrenia and Related Disorders; Major Depressive Disorder; Bipolar DepressionLast Updated:March 7, 2024Not yet recruiting
Condition(s):Major Depressive DisorderLast Updated:March 3, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.